Literature DB >> 9262538

Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Studies of ocular complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.

.   

Abstract

PURPOSE: To examine associations of systemic and ocular characteristics with severity of cytomegalovirus (CMV) retinitis at time of diagnosis and to compare ocular characteristics of eyes with and without CMV retinitis.
METHODS: Eleven clinical centers, a data coordinating center, and a fundus photograph reading center participated in a randomized, controlled, multicenter clinical trial comparing foscarnet and ganciclovir as primary therapy for previously untreated CMV retinitis in 240 patients with AIDS.
RESULTS: The systemic characteristics marginally associated with the percentage of retina affected by CMV in a patient's worse eye at diagnosis were chronic fever, weight loss, and number of HIV-related illnesses. A positive CMV blood culture at diagnosis was similarly associated with bilateral disease. Laboratory measures of disease did not correlate well with measures of CMV retinitis severity. Many eyes with CMV retinitis had no or minimal lesion hemorrhage, but most had signs of inflammation. Patients often reported visual symptoms for involved eyes. The worse eyes (the eye with lesions covering the most retinal area) of patients with bilateral disease had greater retinal involvement, more lesions, and fewer degrees of visual field than did involved eyes of patients with unilateral disease. Visual symptoms, inflammation, indolent retinitis, and hemorrhagic lesions were associated with a greater percentage of retina affected by CMV.
CONCLUSIONS: The findings support viremia as a mechanism of spread for untreated disease. Visual symptoms and signs of ocular inflammation were indicators both of the presence of CMV retinitis and of greater extent of retinal area covered by CMV retinitis lesions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9262538

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  11 in total

1.  Role of human cytomegalovirus genotype polymorphisms in AIDS patients with cytomegalovirus retinitis.

Authors:  Jens-Uwe Vogel; Jürgen Otte; Frank Koch; Hermann Gümbel; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Med Microbiol Immunol       Date:  2012-06-06       Impact factor: 3.402

2.  Cytomegalovirus retinitis and the acquired immunodeficiency syndrome--bench to bedside: LXVII Edward Jackson Memorial Lecture.

Authors:  Douglas A Jabs
Journal:  Am J Ophthalmol       Date:  2010-12-18       Impact factor: 5.258

3.  Clinical features of newly diagnosed cytomegalovirus retinitis in northern Thailand.

Authors:  Somsanguan Ausayakhun; Jeremy D Keenan; Sakarin Ausayakhun; Choeng Jirawison; Claire M Khouri; Alison H Skalet; David Heiden; Gary N Holland; Todd P Margolis
Journal:  Am J Ophthalmol       Date:  2012-01-20       Impact factor: 5.258

4.  CMV retinopathy in the antiretroviral therapy era: prevention, diagnosis, and management.

Authors:  Lisa Barrett; Sharon Walmsley
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

5.  The human eye (retina): a site of persistent HCMV infection?

Authors:  Jens-Uwe Vogel; Corinna Fleckenstein; Mathias Wagner; Hermann O C Gümbel; Dirk Theegarten; Jindrich Cinatl; Hans Wilhelm Doerr
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-01-26       Impact factor: 3.117

6.  Prevalence and Characteristics of Cytomegalovirus Ocular Disease in Children: A Multi-Center Study.

Authors:  Carmel L Mercado; Colin P Froines; Eric D Gaier; Qinyun Wang; Maanasa Indaram; Michael J Wan; Ankoor S Shah; Euna B Koo
Journal:  Clin Ophthalmol       Date:  2022-07-08

7.  Optimal management of cytomegalovirus retinitis in patients with AIDS.

Authors:  Michael W Stewart
Journal:  Clin Ophthalmol       Date:  2010-04-26

8.  A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency.

Authors:  M N Prichard; N Gao; S Jairath; G Mulamba; P Krosky; D M Coen; B O Parker; G S Pari
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

9.  Posterior subhyaloid precipitates in cytomegalovirus retinitis.

Authors:  Raquel Goldhardt; Ninel Z Gregori; Thomas Albini; Shalini Yalamanchi; Andres Emanuelli
Journal:  J Ophthalmic Inflamm Infect       Date:  2011-07-29

10.  Cytomegalovirus retinitis in a patient with dermatomyositis.

Authors:  Hae-Rim Kim; Sung-Dong Kim; Sang-Hyon Kim; Chong-Hyun Yoon; Sang-Heon Lee; Sung-Hwan Park; Ho-Youn Kim
Journal:  Clin Rheumatol       Date:  2006-03-15       Impact factor: 3.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.